EICHOR
● Completed
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Condition: Osteosarcoma · Ewing Sarcoma · Rhabdomyosarcoma · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
About this study
The purpose of this study is to see if nab-paclitaxel combined with gemcitabine prevents the formation or growth of tumors in participants with relapsed or refractory osteosarcoma, Ewing sarcoma, rhabdomyosarcoma and other soft tissue sarcoma and to measure the length of time during and after treatment that their disease does not get worse. Researchers also want to find out if nab-paclitaxel combined with gemcitabine is safe and tolerable.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham, Alabama, United States | — |
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| Connecticut Children's Medical Center | Hartford, Connecticut, United States | — |
| A.I. duPont Hospital for Children, Delaware - Nemours | Wilmington, Delaware, United States | — |
| Shand's Hospital for Children at the University of Florida | Gainesville, Florida, United States | — |
| Nemours Children's Clinic | Jacksonville, Florida, United States | — |
| Holtz Children's Hospital at the University of Miami | Miami, Florida, United States | — |
| H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center | Tampa, Florida, United States | — |
| University of Kentucky | Lexington, Kentucky, United States | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore, Maryland, United States | — |
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | — |
| Carolinas Medical Center, Levine Cancer Institute | Charlotte, North Carolina, United States | — |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02945800